Overcoming the Low Bioavailability of Apigenin: Therapeutic Efficacy for Androgenetic Alopecia Through Topical Administration

    November 2025 in “ Food Science & Nutrition
    Yanxi PENG, Huan Zhou, Yiqing Sun, Dane Huang, Chao Zhao
    New to Minoxidil? There is a guide in the encyclopedia. Read the guide →
    Studysummary In this study, researchers found that topical apigenin promoted hair growth in a testosterone-induced alopecia mouse model, with effects comparable to minoxidil, suggesting a potential treatment approach for androgenetic alopecia through the Wnt signaling pathway.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study examines the use of topical apigenin, a flavonoid with anti-inflammatory and antioxidant properties, to treat androgenetic alopecia (AGA) by enhancing its bioavailability. Conducted on 32 C57BL/6 mice, the research found that apigenin significantly increased hair growth, particularly between days 24 and 29, and outperformed minoxidil in certain areas. Apigenin upregulated key hair growth genes and interacted with targets like NADPH oxidase 4 and cyclin-dependent kinase 5, suggesting its role in activating the Wnt signaling pathway. These results indicate that apigenin could be a promising natural treatment for AGA, offering an alternative with fewer side effects compared to current therapies.
    Discuss this study in the Community →

    Research cited in this study

    12 / 12 results